Alpha galactosidase for the Industry
M2001 as Prospective Drug for the Metabolic Syndrome
Evogene and biogemaa are engaging in a multiyear collaboration project to deliver corn varieties with improved tolerance to abiotic stress (mainly drought resistance) using gene constructs which have been demonstrated in other plants.
The diagnostic system is a fluorescent-based, microsphere assay using flow cytometry detection and analysis to identify viral proteases in biological samples
Increasing the bioavailability and targeted delivery of active ingredients - curcumin.
Human recombinant fsh will be expressed in engineered yeast cells and purified to homogeneity to meet fsh quality currently marketed. The unique feature of the project is a cost-effective process of human glycosylation and sialylation of fsh, driven by human genes, in a non-human organism.
A recombinant protein purification platform based on cim(r) convective interaction media monolith technology will be developed to significantly decrease protein purification time and costs. The project will result in novel, technical, superior products and services and lower production costs.
The need of growth systems capable of growing cells in physiological 3d culture for therapeutic applications is rapidly increasing. The purpose is the development of novel technology that will allow the growth of 3d cells & tissue cultures in disposable controlled bioreactors system.
To develop a health monitoring device integrating: the world's first proven technology for noninvasive monitoring of hemoglobin for anemia diagnosis and hemorrhage detection; additional parameters (heart rate,oxygen saturation,temperature); finger based blood pressure sensor; remote monitoring.
This project will utilize innovative peptide design technology, unique peptide synthesis and modification capabilities and specialized activity testing models for the generation of innovative toll-like receptor antagonists and agonists. These will be used as both, research tools and drug candidates.